Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-08-08

FDA Approved: ZAFIRLUKAST — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for Zafirlukast submitted by Strides Pharma Science Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zafirlukast (zafirlukast)

Snippet

SUPPL AP for ZAFIRLUKAST (ZAFIRLUKAST)